prof. dr. H.J. (Hidde) Haisma

Professor Therapeutic Gene Modulation

prof. dr. H.J. (Hidde) Haisma
Telephone:
+31 50 36 38174 (Secretariat)
E-mail:
h.j.haisma rug.nl

Research

Postal address:
A Deusinglaan1
Gebouw 3211, ruimte 0306
9713 AV
Groningen
Netherlands
Phone: +31 50 363 6865
  1. 2008
  2. 2007
  3. 2006
  4. Visser, A. E., Verschure, P. J., Gommans, W. M., Haisma, H. J., & Rots, M. G. (2006). Step into the Groove: Engineered Transcription Factors as Modulators of Gene Expression. In JC. Hall, JC. Dunlap, T. Friedmann, & VanHeyningen (Eds.), ADVANCES IN GENETICS (pp. 131-+). (Advances in Genetics; Vol. 56). SAN DIEGO: Academic Press. https://doi.org/10.1016/S0065-2660(06)56004-3
  5. Mahasreshti, PJ., Kataram, M., Wu, HJ., Yalavarthy, LP., Carey, D., Dent, P., ... Curiel, DT. (2006). Ovarian cancer targeted adenoviral-mediated mda-7/IL-24 gene therapy. Gynecologic Oncology, 100(3), 521-532. https://doi.org/10.1016/j.ygyno.2005.08.042
  6. Haisma, HJ., De Hon, O., Sollie, P., & Vorstenbosch, J. (2006). Genetische doping. Nederlands Tijdschrift voor Klinische Chemie en Laboratoriumgeneeskunde, 31(1), 19.
  7. Haisma, H., Coward, W. A., Visser, G. H., Vonk, R. J., Wells, C. K., Wright, A., & Victora, C. G. (2006). Socio-economic and environmental factors influence energy utilisation in Brazilian breast-fed infants. J. Nutrition, 136, 2945 - 2951.
  8. 2005
  9. Oosterhoff, D., Overmeer, RM., de Graaf, M., van der Meulen, IH., Giaccone, G., van Beusechem, VW., ... Gerritsen, WR. (2005). Adenoviral vector-mediated expression of a gene encoding secreted, EpCAM-targeted carboxylesterase-2 sensitises colon cancer spheroids to CPT-11. British Jounal of Cancer, 92(5), 882-887. https://doi.org/10.1038/sj.bjc.6602362
  10. Lu, B., Makhija, SK., Nettelbeck, DM., Rivera, AA., Komarova, S., Zhou, F., ... Zhu, ZB. (2005). Evaluation of tumor-specific promoter activities in melanoma. Gene Therapy, 12(4), 330-338. https://doi.org/10.1038/sj.gt.3302385
  11. Haisma, H. J., & de Hon, O. (2005). Ziek, beter, best: van gentherapie tot genetische doping. In Beter dan Goed, over Genetica en de toekomst van Topsport (pp. 120 - 137). Diemen: Veen Magazines B.V..
  12. 2004
  13. Kirby, TO., Rivera, A., Rein, D., Ulasov, N. V., Breidenbach, M., Kataram, M., ... Curiel, DT. (2004). A novel ex vivo model system for evaluation of conditionally replicative adenoviruses therapeutic efficacy and toxicity. Clin.Cancer Res., 10(24), 8697 - 8703.
  14. Leath, CA., Kataram, M., Bhagavatula, P., Gopalkrishnan, RV., Dent, P., Fisher, PB., ... Mahasreshti, PJ. (2004). Infectivity enhanced adenoviral-mediated mda-7/IL-24 gene therapy for ovarian carcinoma. Gynecologic Oncology, 94(2), 352 - 362. https://doi.org/10.1016/j.ygyno.2004.04.028
  15. 2003
  16. van Beusechem, V. W., Mastenbroek, D. C., Van den Doel, P. B., Lamfers, M. L., Grill, J., Wurdinger, T., ... Gerritsen, W. R. (2003). Conditionally replicative adenovirus expressing a targeting adapter molecule exhibits enhanced oncolytic potency on CAR-deficient tumors. Gene Therapy, 10(23), 1982-1991. https://doi.org/10.1038/sj.gt.3302103
  17. Bruell, D., Stocker, M., Huhn, M., Redding, N., Kupper, M., Schumacher, P., ... Barth, S. (2003). The recombinant anti-EGF receptor immunotoxin 425(scFv)-ETA' suppresses growth of a highly metastatic pancreatic carcinoma cell line. Int.J.Oncol., 23(4), 1179-1186.
  18. Mahasreshti, P. J., Kataram, M., Wang, M. H., Stockard, C. R., Grizzle, W. E., Carey, D., ... Curiel, D. T. (2003). Intravenous delivery of adenovirus-mediated soluble FLT-1 results in liver toxicity. Clin.Cancer Res., 9(7), 2701 - 2710.
  19. Haisma, HJ., & Rots, MG. (2003). State of the art in gene therapy. In CTS. Sibinga, & LFM. DeLeij (Eds.), CELLULAR ENGINEERING AND CELLULAR THERAPIES (pp. 171-187). (DEVELOPMENTS IN HEMATOLOGY AND IMMUNOLOGY; Vol. 38). DORDRECHT: Springer.
  20. 2002
  21. de Gruijl, TD., Luykx-de Bakker, SA., Tillman, BW., van den Eertwegh, AJM., Buter, J., Lougheed, SM., ... Gerritsen, WR. (2002). Prolonged maturation and enhanced transduction of dendritic cells migrated from human skin explants after in situ delivery of CD40-targeted adenoviral vectors. Journal of Immunology, 169(9), 5322-5331.
  22. Oosterhoff, D., Pinedo, HM., van der Meulen, IH., Sone, T., Kruyt, FA., van Beusechem, VW., ... Gerritsen, WR. (2002). Secreted and tumour targeted human carboxylesterase for activation of irinotecan. British Jounal of Cancer, 87(6), 659-664. https://doi.org/10.1038/sj.bjc.6600519
  23. Dirven, CMF., Grill, J., Lamfers, MLM., Van der Valk, P., Leonhart, AM., Van Beusechem, VW., ... Gerritsen, WR. (2002). Gene therapy for meningioma: improved gene delivery with targeted adenoviruses. Journal of Neurosurgery, 97(2), 441-449.

ID: 207456